Cookies?
Library Header Image
LSE Research Online LSE Library Services

Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis

Violato, Mara, Gray, Alastair, Papanicolas, Irene ORCID: 0000-0002-8000-3185 and Ouellet, Melissa (2012) Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLOS ONE, 7 (7). e41308. ISSN 1932-6203

[img]
Preview
PDF
Download (685kB) | Preview

Identification Number: 10.1371/journal.pone.0041308

Abstract

Background Despite the considerable health impact of coeliac disease (CD), reliable estimates of the impact of diagnosis on health care use and costs are lacking. Aims To quantify the volume, type and costs, in a United Kingdom primary care setting, of healthcare resources used by individuals diagnosed with CD up to ten years before and after diagnosis, and to estimate medical costs associated with CD. Methods A cohort of 3,646 CD cases and a parallel cohort of 32,973 matched controls, extracted from the General Practice Research Database (GPRD) over the period 1987–2005 were used i) to evaluate the impact of diagnosis on the average resource use and costs of cases; ii) to assess direct healthcare costs due to CD by comparing average resource use and costs incurred by cases vs. controls. Results Average annual healthcare costs per patient increased by £310 (95% CI £299, £320) after diagnosis. CD cases experienced higher healthcare costs than controls both before diagnosis (mean difference £91; 95% CI: £86, £97) and after diagnosis (mean difference £354; 95% CI: £347, £361). These differences were driven mainly by higher test and referral costs before diagnosis, and by increased prescription costs after diagnosis. Conclusions This study shows significant additional primary care costs associated with coeliac disease. It provides novel evidence that will assist researchers evaluating interventions in this area, and will challenge policymakers, clinicians, researchers and the public to develop strategies that maximise the health benefits of the resources associated with this disease.

Item Type: Article
Official URL: http://www.plosone.org/
Additional Information: © 2012 The Authors
Divisions: LSE Health
Subjects: R Medicine > RA Public aspects of medicine
Date Deposited: 11 Oct 2012 13:24
Last Modified: 15 Mar 2024 03:06
URI: http://eprints.lse.ac.uk/id/eprint/46702

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics